StopAfib.org is among a group of experts calling today for urgent action to prevent an atrial fibrillation stroke crisis in Latin America. Action for Stroke Prevention, a group of health experts from across the globe, is launching a new report, How Can We Avoid a Stroke Crisis in Latin America?, at the International Society for [...]
Rivaroxaban (Xarelto) Effective for Atrial Fibrillation Patients with High Stroke Risk
Just ahead of the FDA Advisory Committee hearing on rivaroxaban for stroke prevention in atrial fibrillation, we report in more depth on the ROCKET-AF trial results published recently in the New England Journal of Medicine. Rivaroxaban was shown to be as effective as warfarin (Coumadin) for stroke prevention in a high-risk afib population. To learn [...]
New Atrial Fibrillation in Primary Care (AFIP) Tool Useful for Afib Patients
A brand new tool, Atrial Fibrillation in Primary Care (AFIP), was just released at the European Society of Cardiology meeting in Paris. This tool may be useful for afib patients and their caregivers, especially those who are newly-diagnosed with atrial fibrillation, in working with doctors. Two members of the StopAfib.org Global Medical Advisory Board are [...]
What Everyone with Atrial Fibrillation Should Know about Multaq (dronedarone)
As a patient, you probably see lots of hype-filled reports about various drugs. After a drug is approved, there’s an inevitable blitz of negative publicity which often scares people away from important new solutions that could help them. There has been so much news lately about Multaq (dronedarone), the drug designed to provide the benefits [...]
Dr. Elaine Hylek on Xarelto and Pradaxa, New Alternatives to Warfarin (Coumadin) — Video
The US FDA has just announced that on September 8, 2011, the FDA Cardiovascular and Renal Drugs Advisory Committee will meet to review whether to recommend approval of rivaroxaban (brand name Xarelto), an alternative to warfarin, for stroke prevention in atrial fibrillation. In this recent video interview, Dr. Elaine Hylek, a leading anticoagulant authority, discussed [...]
Susan Lucci and Husband Launch Pledge to Learn about Atrial Fibrillation and Stroke
When the leading man in her life was diagnosed with atrial fibrillation (afib), actress Susan Lucci jumped into action and pledged to learn everything she could about his condition. Now she and her husband, Helmut Huber, ask you to join them in taking the Facing AFib Pledge to learn more about atrial fibrillation, partner with [...]
New report, How Can We Avoid a Stroke Crisis in the Asia-Pacific Region?, Is Aimed at Avoiding Atrial Fibrillation Strokes
StopAfib.org is among a group of experts calling today for urgent action to prevent an atrial fibrillation stroke crisis in the Asia-Pacific region. Action for Stroke Prevention, a group of health experts from across the globe, is launching a new report, How Can We Avoid a Stroke Crisis in the Asia-Pacific Region?, at the 18th [...]
Team AFib Invites You to Webinar “AFib: When Stroke Strikes” May 3, 2011
In honor of National Stroke Awareness Month (May), Team AFib invites you to our inaugural webinar “AFib: When Stroke Strikes”, hosted by the National Stroke Association. A live expert panel will help you learn to recognize and respond quickly to afib stroke signs and symptoms. StopAfib.org is a member of Team AFib. To learn more [...]
Guest Post by Dr. John Mandrola: More Dabigatran (Pradaxa) News
Dr. John Mandrola shares a great update on the latest info regarding dabigatran (Pradaxa, Pradax). Dr. Mandrola not only treats atrial fibrillation patients, but he has also experienced afib himself. I have become an AF-doctor. That means my most exciting aspect of medicine is terminating AF with watts delivered through a catheter. “Got it.” In [...]
Atrial Fibrosis, Not Afib Type, Linked to Atrial Fibrillation Strokes
Researchers at the Comprehensive Arrhythmia Research and Management Center (CARMA) in Utah have been studying the relationship between atrial fibrillation, atrial fibrosis, and catheter ablation outcomes for many years. Now, they’ve applied their knowledge of quantifying atrial fibrosis to stroke risk assessment and found that the amount of atrial fibrosis, not type of afib, is [...]
